HKU_vol23_issue 2_ebook_amended

28 Inside The Faculty Inside the Faculty In response to the HKSAR Government’s initiative to turn Hong Kong into a centre of biomedical innovation and technology, HKU, Institut Pasteur (IP) and Hong Kong Science and Technology Parks Corporation (HKSTP) announced that they would establish an interdisciplinary research centre for immunology, infection and personalised medicine within the HKSTP’s healthcare HKU Collaborates on Biomedical Innovation with Institut Pasteur and Hong Kong Science and Technology Parks Corporation technologies research cluster (Health@Inno Cluster). A Memorandum of Understanding Signing Ceremony was held in Paris on June 21, 2018, with signatories including Professor Gabriel M Leung （梁卓偉） , HKU’s Dean of Medicine; Professor Stewart Cole , President of Institut Pasteur; and Mr Albert Wong （黃克強） , Chief Executive Officer of HKSTP, and in the presence of a high-level delegation led by The Hon Mrs Carrie Lam Cheng Yuet-ngor （林鄭月娥） , Chief Executive of the Hong Kong SAR; and Mr Nicholas W Yang （楊偉雄） , Secretary for Innovation and Technology. By combining the power of academia and industry, the research centre will support Hong Kong’s transformation into an international innovation and technology hub for the Guangdong- Hong Kong-Macau Bay Area. BACMUNO Biotechnology Ltd, an HKU start-up working on the discovery, development and commercialisation of novel bacterial based cancer immunotherapies, received an outstanding award in the X-plan graduation roadshow. The Hon Mrs Carrie Lam Cheng Yuet-ngor （林鄭月娥） , Chief Executive of the Hong Kong SAR, awarded the prize. The five winning teams will enter into the next incubation supported by HK X-Foundation, with three expected to receive investment of up to HK$100 million. The bio-pharmaceutical company is a spin off from Professor Huang Jiandong’s （黃建東） Lab in the School of Biomedical Sciences, Faculty of Medicine. HKU Bio-pharmaceutical Company Wins Outstanding Start-up Award